H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $2.00 price target on Rockwell Medical Technologies (NASDAQ: RMTI).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments